SCHEMBL6163684

SCHEMBL6163684

NC(=O)C1C(=O)CCN1C(=O)[CH]Cc1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.35
SIRT1 Q96EB6 1/20 0.35
CYP2C19 P33261 1/20 0.35
RAB9A P51151 2/20 0.34
LMNA P02545 1/20 0.34
TACR1 P25103 3/20 0.34
LTA4H P09960 2/20 0.34
GAA P10253 1/20 0.34
MTNR1B P49286 1/20 0.33
ALDH1A1 P00352 3/20 0.33
PKM P14618 1/20 0.33
ITGB3 P05106 1/20 0.33
ITGA2B P08514 1/20 0.33
DPP4 P27487 1/20 0.32
DPP8 Q6V1X1 1/20 0.32
DPP9 Q86TI2 1/20 0.32
DPP7 Q9UHL4 1/20 0.32
NPC1 O15118 1/20 0.32
MAPT P10636 1/20 0.32
NFKB1 P19838 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164555 0.86 PARP1 (0.35) SMN1; SMN2SIRT1CYP2C19LMNATACR1
SCHEMBL6164063 0.84 ACE (0.47) MTNR1BALDH1A1
SCHEMBL6163349 0.80 PKM (0.34) SMN1; SMN2CYP2C19TACR1GAAALDH1A1
SCHEMBL812802 0.76 SMN1; SMN2 (0.55) SMN1; SMN2CYP2C19RAB9ANPC1
SCHEMBL3138570 0.75 SPHK1 (0.50) RAB9ADPP4DPP8DPP9DPP7
SCHEMBL4086816 0.74 TACR1 (0.44) SMN1; SMN2CYP2C19LMNATACR1GAA
SCHEMBL6163270 0.74 SPHK1 (0.47) RAB9ALTA4HALDH1A1DPP4NPC1
SCHEMBL4095230 0.74 TACR1 (0.44) SMN1; SMN2CYP2C19LMNATACR1GAA
SCHEMBL6163040 0.74 RIPK1 (0.36) SMN1; SMN2SIRT1CYP2C19LMNATACR1
SCHEMBL6052746 0.74 TACR1 (0.44) SMN1; SMN2CYP2C19LMNATACR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1134213-B1 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER (US) 2005-11-02 EP disclosed
EP-0832065-B1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER (US) 2001-10-10 EP disclosed
EP-1134213-A2 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER INC. (US) 2001-09-19 EP disclosed
US-6277877-B1 GLYCOGEN PHOSPHORYLASE INHIBITOR; ANTIDIABETIC AGENTS PFIZER, INC. 2001-08-21 US disclosed
US-6107329-A HYPOTENSIVE AGENTS; CARDIOVASCULAR DISORDERS PFIZER, INC. (US) 2000-08-22 US disclosed
EP-0832065-A1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER INC. (US) 1998-04-01 EP disclosed
WO-1996039384-A1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER, INC. (US) 1996-12-12 WO disclosed